Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 ( GFPT2 ) is a prognostic marker in gastric cancer

3 Jul 2023

Abstract excerpt

Glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a rate-limiting enzyme in hexosamine biosynthesis involved in the occurrence and progress of many cancers. What role it plays in gastric cancer (GC) is still unclear. In this study, transcriptome sequencing data from the Harbin Medical University (HMU)-GC cohort and The Cancer Genome Atlas (TCGA) dataset were combined with the HMU-TCGA training cohort...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37395335
DOI: 10.1002/cjp2.333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer‐associated fibroblast expression of glutamine fructose‐6‐phosphate aminotransferase 2 ( GFPT2 ) is a prognostic marker in gastric cancerPMID 37395335Read ↗

Roles of GFPT2 Expression Levels On the Prognosis and Tumor Microenvironment of Colon CancerSemantic proximity Read ↗

Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon CancerSemantic proximity Read ↗

Identification of a novel prognostic model for gastric cancer utilizing glutamine-related genesSemantic proximity Read ↗

A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint InhibitorsSemantic proximity Read ↗

Clinical Values and Functional Analysis Of KMT2A/B/C/D/E/F in Gastric Cancer by Integrated Bioinformatics AnalysisSemantic proximity Read ↗

GLT8D2 is a prognostic biomarker and regulator of immune cell infiltration in gastric cancerSemantic proximity Read ↗

MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and ExperimentsSemantic proximity Read ↗

Characteristics of alpha-fetoprotein-positive gastric cancer revealed by analysis of cancer databases and transcriptome sequencing dataSemantic proximity Read ↗

Profiling Cancer-Associated Fibroblasts (CAFs) in Gastric Cancer and Development of a CAF-Based Prognostic Signature Using Integrated Single-Cell RNA Sequencing and TCGA AnalysisSemantic proximity Read ↗

COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencingSemantic proximity Read ↗

The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancerSemantic proximity Read ↗

Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.